PTAB not such a "death squad", at least for Orange Book pharma patents, study suggests
A new US Patent and Trademark Office (USPTO) study has provided an improved insight into the outcomes of administrative validity challenges made against Orange Book-listed pharmaceutical patents at the Patent Trial and Appeal Board (PTAB). Among…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.